New interventions targeting LEP, NOTCH1, SPRY1, PPARG, ID2, and CIDEA gene network, in addition to what already is going on, can be designed for treatment and prevention of both obesity and tumors. The gene discussed is SPRY1; the disease is obesity due to melanocortin 4 receptor deficiency.